Leishmania mexicana: Participation of NF-κB in the differential production of IL-12 in dendritic cells and monocytes induced by lipophosphoglycan (LPG)

Experimental Parasitology

Volumn 120, Issue 1, 2008, Pages 1-9

  Argueta Donohué, Jesús ^a   Carrillo, Nuria ^a   Valdés Reyes, Leonardo ^a   Zentella, Alejandro ^b   Aguirre García, Magdalena ^a   Becker, Ingeborg ^a   Gutiérrez Kobeh, Laila ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

Author keywords

Dendritic cells (DC); IL 10; IL 12; Leishmania mexicana; LPG; Macrophages (M ); Monocyte derived dendritic cells (moDC); Monocytes; NF B; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; LIPOPHOSPHOGLYCAN;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEISHMANIA MEXICANA; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; GLYCOSPHINGOLIPIDS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LEISHMANIA MEXICANA; MONOCYTES; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

LEISHMANIA MEXICANA;

EID: 48649083371     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.04.002     Document Type: Article

References (58)

1. Aebischer T., Bennett C.L., Pelizzola M., Vizzardelli C., Pavelka N., Urbano M., Capozzoli M., Luchini A., Ilg T., Granucci F., Blackburn C.C., and Ricciardi-Castagnoli P. A critical role for lipophosphoglycan in proinflammatory responses of dendritic cells to Leishmania mexicana. European Journal of Immunology 35 (2005) 476-486
2. Akira S. Mammalian Toll-like receptors. Current Opinion in Immunology 15 (2003) 5-11
3. Andrews C.N., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research 19 (1991) 2499
4. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology 14 (1996) 649-683
5. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Gutierrez-Kobeh L., Ruiz A., Cervantes R., Perez-Torres A., Cabrera N., Gonzalez A., Maldonado C., and Isibasi A. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Molecular and Biochemical Parasitology 130 (2003) 65-74
6. Belkaid Y., Butcher B., and Sacks D.L. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. European Journal of Immunology 28 (1998) 1389-1400
7. Biron C.A., and Gazinelli R.T. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Current Opinion in Immunology 7 (1995) 485-496
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
9. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., and Modlin R.L. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285 (1999) 732-736
10. Brightbill H.D., Plevy S.E., Modlin R.L., and Smale S.T. A prominent role for Sp1 during lipopolysaccharide- mediated induction of the IL-10 promoter in macrophages. Journal of Immunology 164 (2000) 1940-1951
11. Butcher B.A., Leesun K., Johnson P.F., and Denkers E.Y. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. Journal of Immunology 167 (2001) 2193-2201
12. Carrera L., Gazzinelli R.T., Badolato R., Hieny S., Muller W., Kuhn R., and Sacks D.L. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. Journal of Experimental Medicine 183 (1996) 515-526
13. Crawford E.K., Ensor J.E., Kalvakolanu I., and Hasday J.D. The role of 3′ poly(A) tail metabolism in tumor necrosis factor-α regulation. Journal of Biological Chemistry 272 (1997) 21120-21127
14. Dalpke A., and Heeg K. Signal integration following Toll-like receptor triggering. Critical Reviews in Immunology 22 (2002) 217-250
15. De Veer M.J., Curtis J.M., Baldwin T.M., DiDonato J.A., Sexton A., McConville M.J., Handman E., and Schofield L. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. European Journal of Immunology 33 (2003) 2822-2831
16. Frankenburg S., Leibovici V., Mansbach N., Turco S.J., and Rosen G. Effect of glycolipids of Leishmania parasites on human monocyte activity: inhibition by lipophosphoglycan. Journal of Immunology 145 (1990) 4284-4289
17. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology 16 (1998) 225-260
18. Gorak P.M., Engwerda C.R., and Kaye P.M. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. European Journal of Immunology 28 (1998) 687-695
19. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 111 (2002) 927-930
20. Grigoriadis G., Zhan Y., Grumont R.J., Metcalf D., Handman E., Cheers C., and Gerondakis S. The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO Journal 15 (1996) 7099-7107
21. Fujiwara N., and Kobayashi K. Macrophages in inflammation. Currents Drug Targets Inflammation and Allergy 4 (2005) 281-286
22. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annual Review of Immunology 20 (2002) 197-216
23. Kane M.M., and Mosser D.M. The role of IL-10 in promoting disease progression in leishmaniasis. Journal of Immunology 166 (2001) 1141-1147
24. Karin M., and Ben Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kappa B activity. Annual Review of Immunology 18 (2000) 621-663
25. Kim E., Kang B.Y., and Kim T.S. Inhibition of interleukin-12 production in mouse macrophages by hydroquinone, a reactive metabolite of benzene, via suppression of nuclear factor-κB binding activity. Immunology Letters 99 (2005) 24-29
26. Kim S.H., Kim T.S., Kim S.J., Seong C.H., Lee O.H., Lee H.J., and Yoo J.C. Inhibition of interleukin-12 production in mouse macrophages via suppression of nuclear factor-κB binding activity by Phyllostachys nigra var. henonis. Immunopharmacology and Immunotoxicology 29 (2007) 131-139
27. Konecny P., Stagg A.J., Jebbari H., English N., Davidson R.N., and Knight S.C. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. European Journal of Immunology 29 (1999) 1803-1811
28. Lucas M., Zhang X., Prasanna V., and Mosser D.M. ERK activation following macrophage FcγR ligation leads to chromatin modifications at the IL-10 locus. Journal of Immunology 175 (2005) 469-477
29. Machuca C., Mendoza-Milla C., Córdova E., Mejía S., Covarrubias L., Ventura J., and Zentella A. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT. BMC Cell Biology 7 (2006) 9-20
30. Marovich M.A., McDowell M.A., Thomas E.K., and Nutman T.B. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. Journal of Immunology 164 (2000) 5858-5865
31. McConville M.J., Bacic A., Mitchell G.F., and Handman E. Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor. Proceedings of the National Academy of Science USA 84 (1987) 8941-8945
32. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
33. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., and Murphy K.M. Regulation of interleukin 12p40 expression through NF-κB half-site. Molecular and Cellular Biology 15 (1995) 5258-5267
34. Miles S.A., Conrad S.M., Alves R.G., Jeronimo S.M.B., and Mosser D.M. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. Journal of Experimental Medicine 201 (2005) 747-754
35. Naderer T., Vince J.E., and McConville M.J. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Current Molecular Medicine 4 (2004) 649-665
36. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., Rao A.S., and Madara J.L. Procaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289 (2000) 1560-1563
37. Orlandi Jr. P.A., and Turco S.J. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. Journal of Biological Chemistry 262 (1987) 10384-10391
38. Piedrafita D., Proudfoot L., Nikolaev A.V., Xu D., Sands W., Feng G.J., Thomas E., Brewer J., Ferguson M.A.J., Alexander J., and Liew F.Y. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. European Journal of Immunology 29 (1999) 235-244
39. Plevy S.E., Gemberling J.H., Hsu S., Dorner A.J., and Smale S.T. Multiple control elements mediate activation of the murine and human interleukin 12p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Molecular and Cellular Biology 17 (1997) 4572-4588
40. Ponte-Sucre A., Heise D., and Moll H. Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells. Immunology 104 (2001) 462-467
41. Proudfoot L., Nikolaev A.V., Feng G.J., Wei X.Q., Ferguson M.A.J., Brimacombe J.S., and Liew F.Y. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proceedings of the National Academy of Science USA 93 (1996) 10984-10989
42. Proudfoot L., O'Donnell C.A., and Liew F.Y. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. European Journal of Immunology 25 (1995) 745-750
43. Reiner S.L., and Locksley R.M. The regulation of immunity to Leishmania major. Annual Review of Immunology 13 (1995) 151-177
44. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.P., Steinman R.M., and Schuler G. Proliferating dendritic cell progenitors in human blood. Journal of Experimental Medicine 180 (1994) 83-93
45. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Journal of Experimental Medicine 179 (1994) 109-118
46. Sanjabi S., Hoffmann A., Liou H.C., Baltimore D., and Smale S.T. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proceedings of the National Academy of Science USA 97 (2000) 12705-12710
47. Schesser K., Spiik A.K., Dukuzumuremyi J.M., Neurath M.F., Pettersson S., and Wolf-Watz H. The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Molecular Microbiology 28 (1998) 1067-1079
48. Shapira S., Speirs K., Gerstein A., Caamano J., and Hunter C.A. Suppression of NF-κB activation by infection with Toxoplasma gondii. Journal of Infectious Diseases 185 (2002) s66-s72
49. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., and Young H.A. Interaction of NF-kappa B and NFAT with the interferon-promoter. Journal of Biological Chemistry 272 (1997) 30412-30420
50. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Advances in Immunology 70 (1998) 83-243
51. von Stebut E., Belkaid Y., Nguyen B.V., Cushing M., Sacks D.L., and Udey M.C. Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. European Journal of Immunology 30 (2000) 3498-3506
52. von Stebut E., Belkaid Y., Jakob T., Sacks D.L., and Udey M.C. Uptake of Leishmania major amastigotes results in activation and IL-12 release from murine skin-derived dendritic cells: implications for the initiation of anti- Leishmania immunity. Journal of Experimental Medicine 188 (1998) 1547-1552
53. Werling D., Hope J.C., Howard C.J., and Jungi T.W. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like4 receptor agonists. Immunology 111 (2004) 41-52
54. Woelbing F., Lopez S., Moelle K., Belkaid Y., Sunderkoetter C., Verbeek S., Waisman A., Nigg A., Knop J., Udey M., and von Stebut E. Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity. Journal of Experimental Medicine 203 (2006) 177-188
55. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappaB/Rel in induction of nitric oxide synthase. Journal of Biological Chemistry 269 (1994) 4705-4708
56. Xu X., Sunita K., Feng C., Xiong X., Shen H., Maruyama S., Kanoh M., and Asano Y. Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice. Journal of Immunology 167 (2001) 235-241
57. Yoshimoto T., Nagase H., Ishida T., Inoue J., and Nariuchi H. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-kappa B. European Journal of Immunology 27 (1997) 3461-3470
58. Zhu C., Rao K., Xiong H., Gagnidze K., Li F., Horvath C., and Plevy S. Activation of the murine interleukin-12p40 promoter by functional interactions between NFAT and ICSBP. Journal of Biological Chemistry 278 (2003) 39372-39382